HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Massimo Gentile Selected Research
Massimo Gentile Research Topics
Disease
61
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2024 - 01/2002
43
Multiple Myeloma
05/2024 - 03/2010
21
Neoplasms (Cancer)
05/2024 - 06/2005
15
Disease Progression
01/2024 - 08/2003
11
Infections
02/2024 - 09/2002
11
COVID-19
01/2024 - 01/2020
7
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 09/2016
5
Anemia
04/2024 - 01/2002
5
Hematologic Neoplasms (Hematological Malignancy)
01/2024 - 04/2012
5
Neutropenia
01/2022 - 09/2002
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2024 - 10/2016
4
Residual Neoplasm
04/2024 - 01/2015
4
Leukemia
01/2024 - 08/2002
4
Lymphoma (Lymphomas)
12/2022 - 03/2012
4
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2022 - 01/2019
4
Trisomy (Trisomies)
01/2020 - 08/2014
4
Hodgkin Disease (Hodgkin's Disease)
06/2017 - 04/2009
3
Primary Myelofibrosis (Myelosclerosis)
04/2024 - 01/2011
3
Thrombotic Thrombocytopenic Purpura
07/2023 - 04/2018
3
Waldenstrom Macroglobulinemia (Macroglobulinemia)
08/2022 - 01/2015
3
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2018 - 03/2014
3
Lymphocytosis
03/2015 - 09/2008
3
Chromosome Aberrations (Chromosome Abnormalities)
03/2015 - 09/2011
2
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2024 - 10/2021
2
Hemorrhage
01/2024 - 01/2022
2
Smoldering Multiple Myeloma
01/2022 - 04/2015
2
Thrombocytopenia (Thrombopenia)
10/2021 - 04/2018
2
Bronchiolitis
02/2020 - 01/2018
2
B-Cell Lymphoma (Lymphoma, B Cell)
01/2019 - 06/2015
2
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2019 - 01/2016
2
Body Weight (Weight, Body)
01/2019 - 07/2017
1
Amyloidosis
04/2024
1
Sudden Death
01/2024
1
Heart Failure
01/2024
1
Lymphadenopathy
12/2023
Drug/Important Bio-Agent (IBA)
18
Lenalidomide (CC 5013)
FDA Link
01/2024 - 02/2011
18
ibrutinib
IBA
01/2024 - 01/2015
14
Dexamethasone (Maxidex)
FDA Link
Generic
01/2024 - 09/2002
12
Rituximab (Mabthera)
FDA Link
01/2023 - 09/2008
9
Melphalan (Alkeran)
FDA Link
Generic
12/2022 - 11/2011
9
Bendamustine Hydrochloride
FDA Link
01/2021 - 11/2013
8
Prednisone (Sone)
FDA Link
Generic
01/2024 - 06/2002
7
Bortezomib (Velcade)
FDA Link
03/2017 - 03/2010
6
venetoclax
IBA
12/2023 - 11/2017
6
Immunomodulating Agents
IBA
10/2023 - 09/2012
6
fludarabine
IBA
01/2023 - 06/2002
6
elotuzumab
IBA
01/2023 - 01/2021
6
Biomarkers (Surrogate Marker)
IBA
01/2022 - 04/2005
6
Proteins (Proteins, Gene)
FDA Link
01/2020 - 03/2008
5
Proteasome Inhibitors
IBA
10/2023 - 06/2013
5
Interferons
IBA
03/2023 - 01/2020
5
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2023 - 06/2015
5
Dasatinib (BMS 354825)
FDA Link
01/2020 - 03/2014
4
Monoclonal Antibodies
IBA
05/2024 - 01/2021
4
idelalisib
IBA
12/2023 - 01/2015
4
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
01/2020 - 01/2011
4
Thalidomide (Thalomid)
FDA Link
11/2015 - 11/2011
3
Cytokines
IBA
04/2024 - 01/2002
3
Vaccines
IBA
02/2024 - 12/2021
3
thiamine triphosphorate (TTP)
IBA
07/2023 - 04/2018
3
carfilzomib
IBA
12/2022 - 01/2022
3
Antiviral Agents (Antivirals)
IBA
01/2022 - 01/2019
3
obinutuzumab
IBA
01/2022 - 01/2015
3
Oxygen (Dioxygen)
IBA
01/2022 - 01/2020
3
Chlorambucil (Leukeran)
FDA Link
01/2022 - 11/2006
3
Immunoglobulin G (IgG)
IBA
01/2021 - 09/2008
3
ponatinib
IBA
01/2020 - 01/2017
3
Steroids
IBA
01/2020 - 09/2008
3
Alkylating Agents
IBA
01/2020 - 11/2013
3
Hemoglobins (Hemoglobin)
IBA
01/2019 - 09/2008
3
MicroRNAs (MicroRNA)
IBA
01/2015 - 04/2011
2
caplacizumab
IBA
07/2023 - 04/2023
2
Agammaglobulinaemia Tyrosine Kinase
IBA
06/2023 - 10/2022
2
Deferasirox
FDA Link
05/2023 - 06/2014
2
Interferon Lambda
IBA
03/2023 - 01/2018
2
pomalidomide
IBA
01/2023 - 01/2017
2
acalabrutinib
IBA
01/2023 - 01/2020
2
hydroxyethyl methacrylate (HEMA)
IBA
12/2022 - 12/2022
2
Antigens
IBA
06/2022 - 01/2021
2
Anti-Bacterial Agents (Antibiotics)
IBA
01/2021 - 08/2003
2
Filgrastim (Neupogen)
FDA Link
02/2020 - 10/2015
2
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2019 - 09/2002
2
Imatinib Mesylate (Gleevec)
FDA Link
01/2017 - 04/2008
2
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
10/2015 - 09/2002
2
DNA (Deoxyribonucleic Acid)
IBA
07/2014 - 02/2011
1
fms-Like Tyrosine Kinase 3
IBA
05/2024
1
Immunoglobulin Light Chains (Immunoglobulin Light Chain)
IBA
04/2024
1
Amyloid (Amyloid Fibrils)
IBA
04/2024
1
N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamide
IBA
04/2024
1
Janus Kinase Inhibitors
IBA
04/2024
1
blinatumomab
IBA
04/2024
1
selinexor
IBA
03/2024
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2024
Therapy/Procedure
48
Therapeutics
05/2024 - 01/2002
14
Drug Therapy (Chemotherapy)
10/2023 - 01/2002
6
Stem Cell Transplantation
12/2020 - 07/2014
4
Salvage Therapy
12/2022 - 01/2021
3
Immunotherapy
06/2023 - 12/2020
3
Hematopoietic Stem Cell Mobilization
03/2021 - 09/2002
2
Artificial Respiration (Mechanical Ventilation)
07/2021 - 01/2021